Ankylosing Spondylitis (Bekhterev’s Disease)– Pipeline Review, 2019

Ankylosing Spondylitis is one of the commonly observed form of arthritis which causes inflammation in spine which can lead to severe chronic pain and patient discomfort. Depending on the severity and stage of the disease, inflammation in spinal bones can lead to formation of new bones in spine, this condition is called as ankyloses.

The indications of ankylosing spondylitis vary from patient to patient, however, frequent pain, stiffness in lower back and spinal discomfort are commonly observed indications of ankylosing spondylitis amongst others. According to Centres for Disease Control and Prevention (CDC), in 2012, an estimated 2.7 million populations was suffering from ankylosing spondylitis in the U.S.

At the present situation, the treatment for ankylosing spondylitis involves medications, physical therapy, surgery, exercise and good posture practices. Moreover, certain nonsteroidal anti-inflammatory drugs such as indomethacin and naproxen are highly prescribed by physicians to treat ankylosing spondylitis across the globe.

Pharmaceutical companies and research and academic institutes are prominently focusing on studying and developing new treatment options for the celiac disease. For instance; Fengshigutong, which is being studied by Sun Yat-sen University is currently in phase-4 clinical trials to check its efficacy and tolerability for the treatment of ankylosing spondylitis.

At present around 70% of the pipeline candidates for celiac disease are in the phase-3 and phase-4 stage. Majority of the studies have been sponsored by pharmaceutical companies and other drug manufacturers.

Report Description

The report on ‘Ankylosing Spondylitis (Bekhterev’s Disease)– Pipeline Review, 2019’ provides a comprehensive overview of the drugs that are in the R&D pipeline by indication or molecule for Ankylosing Spondylitis (Bekhterev’s Disease). The report provides a thorough analysis of the distribution of the pipeline products by clinical trial stage, indication, company, therapy area and details such as clinical trial stage, sponsor, description on every product in the pipeline. Products in the preclinical and clinical stage along with dormant & discontinued pipeline candidates are included in the report. The report also covers additional insights such as epidemiology overview and current market scenario for Ankylosing Spondylitis (Bekhterev’s Disease).

The report on ‘Ankylosing Spondylitis (Bekhterev’s Disease)– Pipeline Review, 2019’, which is built by following a robust research methodology involving primary interviews and desk research, provides a complete overview of the R&D activity and pipeline products to assist companies in developing growth strategies and identifying emerging players.

Report Scope

• Thorough assessment of the pipeline products by areas such as development stage; route of administration; drug class; indication; sponsor; molecule type and drug target
• Comprehensive profiles of the pipeline products with details such as company overview; product description; R&D status; development activities; mechanism of action; molecule type; development stage; indications; funding and route of administration
• Overview of dormant and discontinued pipeline products
• Key insights in relation to the epidemiology of conditions being treated by the pipeline products and overview of the addressable or current market for the pipeline products
• Overview of the latest developments; news articles, press releases and relevant conferences

Report Methodology

• All pipeline reports are built through the analysis of data primarily collected through credible desk research sources. Secondary research is supplemented by interviews conducted with key opinion leaders.
• Desk research sources includes global and regional clinical trials databases; annual reports, websites, press releases & investor presentations of companies; white papers; news articles; reports published by industry associations; articles/reports published on databases such as NCBI, ResearchGate; internal databases

Reasons to Buy this Report

• Develop effective growth strategies based on comprehensive overview of the R&D activity and pipeline products for Ankylosing Spondylitis (Bekhterev’s Disease)
• Identify emerging players or competition in the market based on pipeline products and develop strategies to counter the emergence of these players
• Identify the focus of leading players in relation to R&D for Ankylosing Spondylitis (Bekhterev’s Disease)
• Identify potential companies from a partnership or acquisition point of view based on current synergy in R&D activities or strategies to diversify R&D focus to drive growth in business
• Analyse the reasons behind dormant and discontinued products to make changes in the R&D focus if necessary